Nuvectis Pharma, Inc. (NVCT) Earnings
|
Expand Research on NVCT
| Next EPS Date | 8/11/26 | EPS Growth Rate | -6.7% |
|---|---|---|---|
| Average EPS % Beat Rate | +56.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +7.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/11/26  |
Q226 | N/A | -$0.32 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/12/26 |
Q126 | N/A | -$0.31 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/10/26 |
Q425 | N/A | -$0.25 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/11/25 |
Q325 | N/A | -$0.25 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/5/25 |
Q225 | -$0.30 | -$0.25 | -$0.05 | N/A | N/A | N/A |  | | Details | |
| 5/6/25 |
Q125 | $0.27 | -$0.26 | +$0.53 | N/A | N/A | N/A | | | Details | |
| 3/11/25 |
Q424 | N/A | -$0.26 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/5/24 | Q324 | -$0.24 | -$0.25 | +$0.01 | N/A | N/A | N/A | | | Details |
